Abstract
Purpose
The differential diagnosis of adrenocorticotropic hormone (ACTH)-dependent Cushing’s syndrome remains a challenge in clinical practice. The present study was aimed at assessing the diagnostic performance of pituitary dynamic contrast-enhanced magnetic resonance imaging (dMRI), high-dose dexamethasone suppression test (HDDST), and a combination of both tests for patients with ACTH-dependent Cushing’s syndrome.
Methods
A total of 119 consecutive patients with ACTH-dependent Cushing’s syndrome confirmed surgically were enrolled: 101 with proven Cushing’s disease and 18 with proven ectopic ACTH syndrome. All patients underwent pituitary dMRI and HDDST. The sensitivity and specificity of pituitary dMRI, HDDST, and a combination of both tests were determined.
Results
The sensitivity and specificity of pituitary dMRI for diagnosing Cushing’s disease were 80.2 and 83.3%, respectively, with a positive predictive value of 96.4%. The sensitivity and specificity of HDDST were 70.3 and 77.8%, respectively, with positive predictive value of 94.7%. A combination of both tests showed that the combined criteria of more than 50% suppression of serum cortisol on HDDST and a positive pituitary dMRI finding yielded a high specificity of 94.4 and sensitivity of 59.4%. The combined criteria of more than 68% suppression on HDDST and/or a positive pituitary dMRI finding yielded a sensitivity of 86.1% and specificity of 83.3%.
Conclusions
Pituitary dMRI was superior to HDDST in the differential diagnosis of ACTH-dependent Cushing’s syndrome. HDDST is recommended in combination with pituitary dMRI to establish a diagnosis process because of the significantly increased specificity with the combination.
Similar content being viewed by others
Abbreviations
- CS:
-
Cushing’s syndrome
- ACTH:
-
adrenocorticotropic hormone
- CD:
-
Cushing’s disease
- EAS:
-
ectopic ACTH syndrome
- dMRI:
-
dynamic contrast-enhanced magnetic resonance imaging
- HDDST:
-
high-dose dexamethasone suppression test
- BIPSS:
-
bilateral inferior petrosal sinus sampling
- CRH:
-
corticotrophin-releasing hormone
- PET:
-
positron emission tomography.
References
F. Pecori Giraldi, L.M. Cavallo, F. Tortora, R. Pivonello, A. Colao, P. Cappabianca, F. Mantero, The role of inferior petrosal sinus sampling in ACTH-dependent Cushing’s syndrome: review and joint opinion statement by members of the Italian Society for Endocrinology, Italian Society for Neurosurgery, and Italian Society for Neuroradiology. Neurosurgical focus 38(2), E5 (2015). https://doi.org/10.3171/2014.11.Focus14766
M. Barbot, L. Trementino, M. Zilio, F. Ceccato, N. Albiger, A. Daniele, A.C. Frigo, R. Mardari, G. Rolma, M. Boscaro, G. Arnaldi, C. Scaroni, Second-line tests in the differential diagnosis of ACTH-dependent Cushing’s syndrome. Pituitary 19(5), 488–495 (2016). https://doi.org/10.1007/s11102-016-0729-y
G. Reimondo, P. Paccotti, M. Minetto, A. Termine, G. Stura, M. Bergui, A. Angeli, M. Terzolo, The corticotrophin-releasing hormone test is the most reliable noninvasive method to differentiate pituitary from ectopic ACTH secretion in Cushing’s syndrome. Clin. Endocrinol. 58(6), 718–724 (2003). https://doi.org/10.1046/j.1365-2265.2003.01776.x
M. Terzolo, G. Reimondo, A. Alì, G. Borretta, F. Cesario, A. Pia, P. Paccotti, A. Angeli, The limited value of the desmopressin test in the diagnostic approach to Cushing’s syndrome. Clin. Endocrinol. 54(5), 609–616 (2001). https://doi.org/10.1046/j.1365-2265.2001.01260.x
Nishioka, H., Yamada, S.: Cushing’s Disease. Journal of clinical medicine 8(11) (2019). https://doi.org/10.3390/jcm8111951
I.S. Kaskarelis, E.G. Tsatalou, S.V. Benakis, K. Malagari, I. Komninos, D. Vassiliadi, S. Tsagarakis, N. Thalassinos, Bilateral inferior petrosal sinuses sampling in the routine investigation of Cushing’s syndrome: a comparison with MRI. Ajr. Am. J. Roentgenol. 187(2), 562–570 (2006). https://doi.org/10.2214/ajr.05.0557
G. Vitale, F. Tortora, R. Baldelli, F. Cocchiara, R.M. Paragliola, E. Sbardella, C. Simeoli, F. Caranci, R. Pivonello, A. Colao, Pituitary magnetic resonance imaging in Cushing’s disease. Endocrine 55(3), 691–696 (2017). https://doi.org/10.1007/s12020-016-1038-y
T.C. Friedman, E. Zuckerbraun, M.L. Lee, M.S. Kabil, H. Shahinian, Dynamic pituitary MRI has high sensitivity and specificity for the diagnosis of mild Cushing’s syndrome and should be part of the initial workup. Horm. Metab. Res. = Horm.- und Stoffwechselforschung = Hormones et. Metab. 39(6), 451–456 (2007). https://doi.org/10.1055/s-2007-980192
L.K. Nieman, B.M. Biller, J.W. Findling, J. Newell-Price, M.O. Savage, P.M. Stewart, V.M. Montori, The diagnosis of Cushing’s syndrome: an Endocrine Society Clinical Practice Guideline. J. Clin. Endocrinol. Metab. 93(5), 1526–1540 (2008). https://doi.org/10.1210/jc.2008-0125
J.F. Bonneville, F. Bonneville, F. Cattin, Magnetic resonance imaging of pituitary adenomas. Eur. Radiol. 15(3), 543–548 (2005). https://doi.org/10.1007/s00330-004-2531-x
L.K. Nieman, B.M. Biller, J.W. Findling, M.H. Murad, J. Newell-Price, M.O. Savage, A. Tabarin, Treatment of Cushing’s syndrome: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 100(8), 2807–2831 (2015). https://doi.org/10.1210/jc.2015-1818
S. Jehle, J.E. Walsh, P.U. Freda, K.D. Post, Selective use of bilateral inferior petrosal sinus sampling in patients with adrenocorticotropin-dependent Cushing’s syndrome prior to transsphenoidal surgery. J. Clin. Endocrinol. Metab. 93(12), 4624–4632 (2008). https://doi.org/10.1210/jc.2008-0979
P. Bansal, A. Lila, M. Goroshi, S. Jadhav, N. Lomte, K. Thakkar, A. Goel, A. Shah, S. Sankhe, N. Goel, N. Jaguste, T. Bandgar, N. Shah, Duration of post-operative hypocortisolism predicts sustained remission after pituitary surgery for Cushing’s disease. Endocr. Connect. 6(8), 625–636 (2017). https://doi.org/10.1530/ec-17-0175
M. Boscaro, G. Arnaldi, Approach to the patient with possible Cushing’s syndrome. J. Clin. Endocrinol. Metab. 94(9), 3121–3131 (2009). https://doi.org/10.1210/jc.2009-0612
N. Colombo, P. Loli, F. Vignati, G. Scialfa, MR of corticotropin-secreting pituitary microadenomas. Ajnr. Am. J. Neuroradiol. 15(8), 1591–1595 (1994)
A. Lienhardt, A.B. Grossman, J.E. Dacie, J. Evanson, A. Huebner, F. Afshar, P.N. Plowman, G.M. Besser, M.O. Savage, Relative contributions of inferior petrosal sinus sampling and pituitary imaging in the investigation of children and adolescents with ACTH-dependent Cushing’s syndrome. J. Clin. Endocrinol. Metab. 86(12), 5711–5714 (2001). https://doi.org/10.1210/jcem.86.12.8086
A. Tabarin, F. Laurent, B. Catargi, F. Olivier-Puel, R. Lescene, J. Berge, F.S. Galli, J. Drouillard, P. Roger, J. Guerin, Comparative evaluation of conventional and dynamic magnetic resonance imaging of the pituitary gland for the diagnosis of Cushing’s disease. Clin. Endocrinol. 49(3), 293–300 (1998). https://doi.org/10.1046/j.1365-2265.1998.00541.x
V. Lefournier, M. Martinie, A. Vasdev, P. Bessou, J.G. Passagia, F. Labat-Moleur, N. Sturm, J.L. Bosson, I. Bachelot, O. Chabre, Accuracy of bilateral inferior petrosal or cavernous sinuses sampling in predicting the lateralization of Cushing’s disease pituitary microadenoma: influence of catheter position and anatomy of venous drainage. J. Clin. Endocrinol. Metab. 88(1), 196–203 (2003). https://doi.org/10.1210/jc.2002-020374
K.E. Graham, M.H. Samuels, G.M. Nesbit, D.M. Cook, O.R. O’Neill, S.L. Barnwell, D.L. Loriaux, Cavernous sinus sampling is highly accurate in distinguishing Cushing’s disease from the ectopic adrenocorticotropin syndrome and in predicting intrapituitary tumor location. J. Clin. Endocrinol. Metab. 84(5), 1602–1610 (1999). https://doi.org/10.1210/jcem.84.5.5654
Z. Liu, X. Zhang, Z. Wang, H. You, M. Li, F. Feng, Z. Jin, High positive predictive value of the combined pituitary dynamic enhanced MRI and high-dose dexamethasone suppression tests in the diagnosis of Cushing’s disease bypassing bilateral inferior petrosal sinus sampling. Sci. Rep. 10(1), 14694 (2020). https://doi.org/10.1038/s41598-020-71628-0
Frete, C., Corcuff, J.B., Kuhn, E., Salenave, S., Gaye, D., Young, J., Chanson, P., Tabarin, A.: Non-invasive Diagnostic Strategy in ACTH-dependent Cushing’s Syndrome. The Journal of clinical endocrinology and metabolism 105(10) (2020). https://doi.org/10.1210/clinem/dgaa409
L.K. Nieman, Is it Time for a New Approach to the Differential Diagnosis of ACTH-Dependent Cushing Syndrome? J. Clin. Endocrinol. Metab. 105(12), e4964–4966 (2020). https://doi.org/10.1210/clinem/dgaa493
D.C. Aron, H. Raff, J.W. Findling, Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing’s syndrome. J. Clin. Endocrinol. Metab. 82(6), 1780–1785 (1997). https://doi.org/10.1210/jcem.82.6.3991
X. Bertagna, L. Guignat, L. Groussin, J. Bertherat, Cushing’s disease. Best practice & research. Clin. Endocrinol. Metab. 23(5), 607–623 (2009). https://doi.org/10.1016/j.beem.2009.06.001
R.R. Lonser, L. Nieman, E.H. Oldfield, Cushing’s disease: pathobiology, diagnosis, and management. J. Neurosurg. 126(2), 404–417 (2017). https://doi.org/10.3171/2016.1.Jns152119
W. Zhang, Y. Yu, H. Tan, C. Wang, J. Li, Z. An, Y. Liu, [Value of desmopressin stimulation test and high dose dexamethasone suppression testin the etiologic diagnosis of ACTH dependent Cushing’s syndrome]. Zhonghua yi xue za zhi 96(11), 845–849 (2016). https://doi.org/10.3760/cma.j.issn.0376-2491.2016.11.004
A. Colao, A. Faggiano, R. Pivonello, F. Pecori Giraldi, F. Cavagnini, G. Lombardi, Inferior petrosal sinus sampling in the differential diagnosis of Cushing’s syndrome: results of an Italian multicenter study. Eur. J. Endocrinol. 144(5), 499–507 (2001). https://doi.org/10.1530/eje.0.1440499
B. Swearingen, L. Katznelson, K. Miller, S. Grinspoon, A. Waltman, D.J. Dorer, A. Klibanski, B.M. Biller, Diagnostic errors after inferior petrosal sinus sampling. J. Clin. Endocrinol. Metab. 89(8), 3752–3763 (2004). https://doi.org/10.1210/jc.2003-032249
P. Grant, D. Dworakowska, P. Carroll, Maximizing the accuracy of Inferior petrosal sinus sampling: validation of the use of Prolactin as a marker of pituitary venous effluent in the diagnosis of Cushing’s disease. Clin. Endocrinol. 76(4), 555–559 (2012). https://doi.org/10.1111/j.1365-2265.2011.04257.x
B. Zampetti, E. Grossrubatscher, P. Dalino Ciaramella, E. Boccardi, P. Loli, Bilateral inferior petrosal sinus sampling. Endocr. Connect. 5(4), R12–25 (2016). https://doi.org/10.1530/ec-16-0029
E. Valassi, B. Swearingen, H. Lee, L.B. Nachtigall, D.A. Donoho, A. Klibanski, B.M. Biller, Concomitant medication use can confound interpretation of the combined dexamethasone-corticotropin releasing hormone test in Cushing’s syndrome. J. Clin. Endocrinol. Metab. 94(12), 4851–4859 (2009). https://doi.org/10.1210/jc.2009-1500
F. Ceccato, C. Artusi, M. Barbot, L. Lizzul, S. Pinelli, G. Costantini, S. Niero, G. Antonelli, M. Plebani, C. Scaroni, Dexamethasone measurement during low-dose suppression test for suspected hypercortisolism: threshold development with and validation. J. endocrinological Investig. 43(8), 1105–1113 (2020). https://doi.org/10.1007/s40618-020-01197-6
Funding
This study was supported by grants from the National Natural Science Foundation of China (No. 81800686) and the Science and Technology Program of Hubei Province (No. 2019CFB316).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
The written informed consent was obtained from all patients that enrolled.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Shi, X., Du, T., Zhu, D. et al. High-dose dexamethasone suppression test is inferior to pituitary dynamic enhanced MRI in the differential diagnosis of ACTH-dependent Cushing’s syndrome. Endocrine 75, 516–524 (2022). https://doi.org/10.1007/s12020-021-02891-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-021-02891-y